SCHEMBL6882200

SCHEMBL6882200

CCOC(=O)Cc1ccc(CNC(=O)c2cc(-c3ccc(-c4ccc(CC(C)=O)cc4OC)cc3)cs2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 5/20 0.50
MMP13 P45452 2/20 0.40
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PPID Q08752 1/20 0.38
KMT2A Q03164 1/20 0.37
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
ROCK2 O75116 2/20 0.36
ROCK1 Q13464 2/20 0.36
MMP2 P08253 1/20 0.36
MMP8 P22894 1/20 0.36
EGFR P00533 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6884793 0.90 MMP12 (0.49) MMP12MMP13ALDH1A1SMN1; SMN2ROCK2
SCHEMBL8342785 0.90 MMP12 (0.59) MMP12MMP13ALDH1A1SMN1; SMN2PPID
SCHEMBL8340728 0.89 MMP12 (0.64) MMP12MMP13ALDH1A1SMN1; SMN2KMT2A
SCHEMBL6882435 0.82 MMP12 (0.55) MMP12MMP13ALDH1A1SMN1; SMN2PPID
SCHEMBL6881457 0.81 MMP12 (0.59) MMP12MMP13ALDH1A1SMN1; SMN2PPID
SCHEMBL6878974 0.81 MMP12 (0.55) MMP12MMP13ALDH1A1SMN1; SMN2PPID
SCHEMBL6881590 0.81 MMP12 (0.75) MMP12MMP13SMN1; SMN2PPIDKMT2A
SCHEMBL8342379 0.80 MMP12 (0.57) MMP12MMP13ALDH1A1SMN1; SMN2PPID
SCHEMBL8338023 0.80 MMP12 (0.57) MMP12MMP13SMN1; SMN2PPIDKMT2A
SCHEMBL6882405 0.79 MMP12 (0.56) MMP12MMP13ALDH1A1PPIDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them WARNER-LAMBERT COMPANY LLC 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040072871-A1 Novel thiophene derivatives, their process of preparation and the pharmaceutical compositions which comprise them MMP11, MMP13, CBR1 MMP12 7/4885MMP13 2/4885ALDH1A1 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.